<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9D53091E-603E-4B64-B5EC-6430D28827FD"><gtr:id>9D53091E-603E-4B64-B5EC-6430D28827FD</gtr:id><gtr:name>Syngenta</gtr:name><gtr:address><gtr:line1>WRO-1004.1.51</gtr:line1><gtr:line2>Schwarzwaldallee 215</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:department>Biosciences</gtr:department><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9D53091E-603E-4B64-B5EC-6430D28827FD"><gtr:id>9D53091E-603E-4B64-B5EC-6430D28827FD</gtr:id><gtr:name>Syngenta</gtr:name><gtr:address><gtr:line1>WRO-1004.1.51</gtr:line1><gtr:line2>Schwarzwaldallee 215</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/45621492-23C9-4AB5-8A02-627D9BE7DAF1"><gtr:id>45621492-23C9-4AB5-8A02-627D9BE7DAF1</gtr:id><gtr:firstName>Tetsuhiro</gtr:firstName><gtr:surname>Kudoh</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F0EEA926-676C-4285-88D6-E4CEC94381D7"><gtr:id>F0EEA926-676C-4285-88D6-E4CEC94381D7</gtr:id><gtr:firstName>Charles</gtr:firstName><gtr:surname>Tyler</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/22D70A28-BC71-4DB0-BD99-879F0B403864"><gtr:id>22D70A28-BC71-4DB0-BD99-879F0B403864</gtr:id><gtr:firstName>Ronny</gtr:firstName><gtr:surname>van Aerle</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER_COI</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FL01548X%2F1"><gtr:id>B730E50B-8F26-48D1-94B5-B58A5CC72A58</gtr:id><gtr:title>FLIP - Transgenic Zebrafish Embryos/Larvae for Systems-Wide Analysis of Endocrine Disrupting Chemicals</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/L01548X/1</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>N/A</gtr:technicalSummary><gtr:potentialImpactText>N/A</gtr:potentialImpactText><gtr:fund><gtr:end>2016-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2013-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>155514</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Syngenta</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Syngenta BB/L01548X/1</gtr:description><gtr:id>417595EB-2427-49DF-88E1-DCBFAAB09EB3</gtr:id><gtr:impact>as above</gtr:impact><gtr:outcomeId>56d7fa961aeb34.91422512-1</gtr:outcomeId><gtr:partnerContribution>as above</gtr:partnerContribution><gtr:piContribution>Through the FLIP we have strengthened considerably our research partnership with AstraZeneca UK and built a new partnership with Syngenta AG, including via internships (Ross Brown and Jon Green) and regular face-to-face meetings. The partnerships have played a role in securing further major research support to Exeter from AstraZeneca for work on pharmaceuticals, three CASE studentship(s) for advancing the use of transgenic fish/imaging and modeling in chemical hazard identification (Syngenta/AstraZeneca) with further grants (Syngenta) and CASE studentships (AstraZeneca) submitted/being developed for submission to BBSRC.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Astra Zeneca BB/L01548X/1</gtr:description><gtr:id>0FB000BC-8ACB-4307-BB87-F67283A29911</gtr:id><gtr:impact>As above</gtr:impact><gtr:outcomeId>56d7f7884d2182.38824198-1</gtr:outcomeId><gtr:partnerContribution>as above</gtr:partnerContribution><gtr:piContribution>Through the FLIP we have strengthened considerably our research partnership with AstraZeneca UK and built a new partnership with Syngenta AG, including via internships (Ross Brown and Jon Green) and regular face-to-face meetings. The partnerships have played a role in securing further major research support to Exeter from AstraZeneca for work on pharmaceuticals, three CASE studentship(s) for advancing the use of transgenic fish/imaging and modeling in chemical hazard identification (Syngenta/AstraZeneca) with further grants (Syngenta) and CASE studentships (AstraZeneca) submitted/being developed for submission to BBSRC.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>SETAC Barcelona 2015 - seminar/workshop 'The use of transgenic zebrafish in ecotoxocology'</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8C34257E-D993-4E54-BC63-CFE8F12AA7DC</gtr:id><gtr:impact>We also coordinated and ran an international seminar/workshop on &amp;quot;The use of transgenic fish in ecotoxicology&amp;quot; held at the Society for Ecotoxicology And Chemistry (SETAC) European Meeting in Barcelona.</gtr:impact><gtr:outcomeId>56d94a4fae5a25.35733485</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Industry CASE studentship - Molly Payne</gtr:description><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>1B68854E-4322-4E33-A757-45A34E76F285</gtr:id><gtr:outcomeId>56d80310448715.64015953</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Syngenta Industry Case studentship</gtr:description><gtr:fundingOrg>Syngenta</gtr:fundingOrg><gtr:id>1ADB2334-A360-4E67-A8FD-21A8DBAE24DC</gtr:id><gtr:outcomeId>56d85895a9d794.20754425</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AstraZeneca - &amp;pound;1.3m</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>AstraZeneca</gtr:fundingOrg><gtr:id>AD37D82C-6595-4E0D-824E-55843B465C2F</gtr:id><gtr:outcomeId>56d7f9a33e8e18.20468846</gtr:outcomeId><gtr:sector>Private</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>1. Industry interchanger (Brown) trained in the culture of the transgenic ERE-GFP zebrafish, imaging using confocal microscopy and advanced molecular technologies including morpholinos, sequencing and bioinformatics.
2. Academic partners gain experience in quantifying morphological and physiological responses in early life stage zebrafish and practical knowledge relating to the application of transgenic zebrafish models and systems biology (adverse outcome pathways) within a regulatory testing framework.
3. Advancement of the ERE-GFP zebrafish model for screening and testing chemicals for oestrogenic activity.
4. Clear case study examples illustrating the utility of the ERE-GFP zebrafish model for informing on health outcomes of exposure to selected EDCs and their molecular mechanisms.
5. Establishment of stronger research partnership between the University of Exeter AstraZeneca and Syngenta, with a view to securing further co-funded research projects, student exchange and outlets for realizing impact of research work at Exeter.</gtr:description><gtr:firstYearOfImpact>2014</gtr:firstYearOfImpact><gtr:id>26C7517A-AE15-49F2-8174-CEDDB4BB71CB</gtr:id><gtr:impactTypes><gtr:impactType>Policy &amp; public services</gtr:impactType></gtr:impactTypes><gtr:outcomeId>546226d9785f85.60961634</gtr:outcomeId><gtr:sector>Chemicals,Communities and Social Services/Policy,Environment,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have applied transgenic fish embryos to identify body targets in fish for chemicals that mimic oestrogen hormones. We show that different environmental oestrogens can induce different tissue responses with different potential health outcomes. This provides a more intelligent system for assessing biological effects of environmental oestrogens and avoids the use of intact animals. We are in the process of establishing the assay in format that will allow for high throughput screening of chemicals and pharmaceuticals. It is envisaged that the new system will result in a reduction and refinement in the use of animals for chemical testing. 

Both the estrogenic plasticizer bisphenol A (BPA) and a BPA metabolite (MBP) activate estrogen response elements primarily in the heart valves via the estrogen receptor (ESR1). Subsequent transcriptomic analysis of micro-dissected heart tissues identified downstream transcriptional targets of BPA and MBP to include krt91 - keratin, col28a1a - collagen, tnnc1b - troponin responsible for cardiomyocyte signalling and cardiac contraction. Collagen deficiency in heart valve ultrastructure in larval fish exposed to 25 &amp;micro;g/L MBP was confirmed by transmission electron microscopy and corresponded with impaired cardiovascular function (reduced heart beat and blood flow rates). 
Conclusions: Our results indicate plausible mechanistic links between BPA exposure and the occurrence of cardiac and/or metabolic disease states, which may be mediated in some part by BPA's metabolite MBP.</gtr:description><gtr:exploitationPathways>Another URL at ttp://www.thenakedscientists.com/HTML/content/interviews/interview/1000021/
The transgenic fish developed have already been supplied to various research laboratories for screening and testing chemicals for oestrogenic activity. The assay is also being employed in support of an OECD test guideline assay for screening chemicals for hormone disrupting chemicals.</gtr:exploitationPathways><gtr:id>D68186B2-BE80-4999-88A7-3DEC1DA2BB7C</gtr:id><gtr:outcomeId>546227ed376821.47238913</gtr:outcomeId><gtr:sectors><gtr:sector>Chemicals,Communities and Social Services/Policy,Education,Environment,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://news.nationalgeographic.com/news/2012/04/120423-fish-glowing-pollution-bpa-environment-science</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>DEFRA - impacts of EE2 and endocrine disruption</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>0CE749B9-AA9B-42F4-8996-55B14F2561D9</gtr:id><gtr:outcomeId>56cf0b489b2db6.88814451</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EU Commission</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>1D5237D1-F499-4582-AF79-76767CB371DD</gtr:id><gtr:impact>This research project has contributed to the validation process for use of transgenic zebrafish in a new OECD guideline test protocol, in a collaboration developed with Dr Francois Brion , INERIS, France..</gtr:impact><gtr:outcomeId>56d803db6e1b20.35729624</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Ministry of Environment for Japan</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>543530A3-E6EA-4BFA-A3B0-18EAFD6984D5</gtr:id><gtr:impact>This research project has contributed to the validation process for use of transgenic zebrafish in a new OECD guideline test protocol.</gtr:impact><gtr:outcomeId>56d8038ebff613.35139597</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Validated proof of concept for a transgenic zebrafish model (i.e. oestrogen responsive ERE-GFP zebrafish) as a reliable, rapid and integrated tool for screening chemical products for endocrine activity in human and environmental safety assessment.</gtr:description><gtr:id>869DA538-42F1-4EE6-876C-449F3A35EF10</gtr:id><gtr:impact>Validated proof of concept for a transgenic zebrafish model (i.e. oestrogen responsive ERE-GFP zebrafish) as a reliable, rapid and integrated tool for screening chemical products for endocrine activity in human and environmental safety assessment.</gtr:impact><gtr:outcomeId>56d7fbb7f06f14.82702168</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Validated proof of concept for a transgenic zebrafish model (i.e. oestrogen responsive ERE-GFP zebrafish) as a reliable, rapid and integrated tool for screening chemical products for endocrine activity in human and environmental safety assessment.</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7A39D557-8A07-4BD6-8079-16ABEAD1278E</gtr:id><gtr:title>High-Content and Semi-Automated Quantification of Responses to Estrogenic Chemicals Using a Novel Translucent Transgenic Zebrafish.</gtr:title><gtr:parentPublicationTitle>Environmental science &amp; technology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b91d5d935b9342a3693a6102870e655"><gtr:id>3b91d5d935b9342a3693a6102870e655</gtr:id><gtr:otherNames>Green JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0013-936X</gtr:issn><gtr:outcomeId>585d3747ea2118.33380864</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDDFDF02-739B-41AD-8968-77520573E946</gtr:id><gtr:title>Early life exposure to ethinylestradiol enhances subsequent responses to environmental estrogens measured in a novel transgenic zebrafish.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b91d5d935b9342a3693a6102870e655"><gtr:id>3b91d5d935b9342a3693a6102870e655</gtr:id><gtr:otherNames>Green JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5aa6564126ea21.59104997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84A59C7C-19AD-4DD3-80C9-8D54FF5CB4F1</gtr:id><gtr:title>Engineering in vivo models for advancing environmental hazard and risk assessment.</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8d18776d134699942b4ad8f0bdde787"><gtr:id>e8d18776d134699942b4ad8f0bdde787</gtr:id><gtr:otherNames>Tyler CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56d948145ad0d7.83969181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>276EFC37-C361-448D-9AE1-CEFB4613C149</gtr:id><gtr:title>Acute Toxicity, Teratogenic, and Estrogenic Effects of Bisphenol A and Its Alternative Replacements Bisphenol S, Bisphenol F, and Bisphenol AF in Zebrafish Embryo-Larvae.</gtr:title><gtr:parentPublicationTitle>Environmental science &amp; technology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77c6a84bffcd350c9a690f614c6c51df"><gtr:id>77c6a84bffcd350c9a690f614c6c51df</gtr:id><gtr:otherNames>Moreman J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0013-936X</gtr:issn><gtr:outcomeId>5aa6561c2cef57.09821024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD0C2304-E62E-47D3-98D3-7B6AC82D3065</gtr:id><gtr:title>Establishment of estrogen receptor 1 (ESR1)-knockout medaka: ESR1 is dispensable for sexual development and reproduction in medaka, Oryzias latipes.</gtr:title><gtr:parentPublicationTitle>Development, growth &amp; differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa3f9a3505371ea63d941dff1feae1b3"><gtr:id>fa3f9a3505371ea63d941dff1feae1b3</gtr:id><gtr:otherNames>Tohyama S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0012-1592</gtr:issn><gtr:outcomeId>5aa6576b73a628.87849690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>740AB843-0507-41C9-B90F-DA4081DF5487</gtr:id><gtr:title>Transgenic fish systems and their application in ecotoxicology.</gtr:title><gtr:parentPublicationTitle>Critical reviews in toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23adaa9e5b08bfb8c63d49eb2dbd8079"><gtr:id>23adaa9e5b08bfb8c63d49eb2dbd8079</gtr:id><gtr:otherNames>Lee O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1040-8444</gtr:issn><gtr:outcomeId>5675dcca9e38e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA77D0B1-9167-49E9-B845-C53E98DE04E2</gtr:id><gtr:title>4-dimensional functional profiling in the convulsant-treated larval zebrafish brain.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4108942cb849b78609404f51a10591eb"><gtr:id>4108942cb849b78609404f51a10591eb</gtr:id><gtr:otherNames>Winter MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5aa6570155a838.31787176</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D1E3FFC-B9E3-41BB-9ACE-C233CCB9F126</gtr:id><gtr:title>Climate change and pollution speed declines in zebrafish populations.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9b67761814ddff96c5ae69363f2d385"><gtr:id>a9b67761814ddff96c5ae69363f2d385</gtr:id><gtr:otherNames>Brown AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>doi_55faa2aa2dac7d0d</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/L01548X/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>48D25546-6ADF-479A-8877-478CCDB1DC1F</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Animal Science</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>17F21DBC-4946-4262-AD07-9914F6EA12F7</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Bioengineering</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>C23BE70F-1EF6-4CC7-88B0-841CB18DD875</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Genetics &amp; development</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>9898EFC8-73AB-4E1E-A207-04A486D9F1A9</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Animal developmental biology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>4A2A69ED-37ED-4980-91A7-E54B4F6A9BC6</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Animal organisms</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>1B737539-A249-4040-879A-633EBED1F6DB</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Environmental biotechnology</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>